Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
The Lindner Center for Research & Education at The Christ Hospital, Cincinnati, Ohio MD Anderson Cancer Center, Houston, Texas Huntsman Cancer Institute and Hospital, University of Utah, Salt Lake City, Utah